Literature DB >> 12452843

Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors.

L Papagno1, V Appay, J Sutton, T Rostron, G M A Gillespie, G S Ogg, A King, A T Makadzanhge, A Waters, C Balotta, A Vyakarnam, P J Easterbrook, S L Rowland-Jones.   

Abstract

The mechanisms underlying non-progression in HIV-1 infection are not well understood; however, this state has been associated previously with strong HIV-1-specific CD8+ T cell responses and the preservation of proliferative CD4+ T cell responses to HIV-1 antigens. Using a combination of interferon-gamma (IFN-gamma) ELISpot assays and tetramer staining, the HIV-1-specific CD8+ T cell populations were quantified and characterized in untreated long-term HIV-1-infected non-progressors and individuals with slowly progressive disease, both in relation to CD4+ T cell responses, and in comparison with responses to cytomegalovirus (CMV) antigens. High levels of CD8+ T cell responses specific for HIV-1 or CMV were observed, but neither their frequency nor their phenotype seemed to differ between the two patient groups. Moreover, while CMV-specific CD4+ T cell responses were preserved in these donors, IFN-gamma release by HIV-1-specific CD4+ T cells was generally low. These data raise questions with regard to the role played by CD8+ T cells in the establishment and maintenance of long-term non-progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452843      PMCID: PMC1906546          DOI: 10.1046/j.1365-2249.2002.02005.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo.

Authors:  Y Laouar; I N Crispe
Journal:  Immunity       Date:  2000-09       Impact factor: 31.745

2.  Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.

Authors:  J C Gea-Banacloche; S A Migueles; L Martino; W L Shupert; A C McNeil; M S Sabbaghian; L Ehler; C Prussin; R Stevens; L Lambert; J Altman; C W Hallahan; J C de Quiros; M Connors
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Frequency and function of HIV-specific CD8(+) T cells.

Authors:  S A Migueles; M Connors
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

6.  Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load.

Authors:  A Oxenius; H F Günthard; B Hirschel; S Fidler; J N Weber; P J Easterbrook; J I Bell; R E Phillips; D A Price
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

7.  Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.

Authors:  M Dalod; M Dupuis; J C Deschemin; D Sicard; D Salmon; J F Delfraissy; A Venet; M Sinet; J G Guillet
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 8.  Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.

Authors:  J Lieberman; P Shankar; N Manjunath; J Andersson
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

9.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

10.  Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.

Authors:  P J Goulder; Y Tang; C Brander; M R Betts; M Altfeld; K Annamalai; A Trocha; S He; E S Rosenberg; G Ogg; C A O'Callaghan; S A Kalams; R E McKinney; K Mayer; R A Koup; S I Pelton; S K Burchett; K McIntosh; B D Walker
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  16 in total

1.  HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.

Authors:  Daniel Mendoza; Cassandra Royce; Laura E Ruff; David R Ambrozak; Máire F Quigley; Thurston Dang; Vanessa Venturi; David A Price; Daniel C Douek; Stephen A Migueles; Mark Connors
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining.

Authors:  Lucas Gonzalez-Nieto; Aline Domingues; Michael Ricciardi; Martin J Gutman; Helen S Maxwell; Nuria Pedreño-Lopez; Varian Bailey; Diogo M Magnani; Mauricio A Martins
Journal:  J Vis Exp       Date:  2016-12-23       Impact factor: 1.355

3.  Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.

Authors:  Laura Milazzo; Antonella Foschi; Cristina Mazzali; Anita Viola; Annalisa Ridolfo; Massimo Galli; Spinello Antinori
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-13       Impact factor: 2.205

4.  Association of IL-12+ DC with High CD3+CD4-DR+ lymphocyte counts in long-term HIV-infected hemophilia patients with clinically stable disease.

Authors:  Volker Daniel; Cord Naujokat; Mahmoud Sadeghi; Rainer Zimmermann; Angela Huth-Kühne; Gerhard Opelz
Journal:  J Clin Immunol       Date:  2007-09-19       Impact factor: 8.317

5.  CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells.

Authors:  Aki Hoji; Nancy C Connolly; William G Buchanan; Charles R Rinaldo
Journal:  Clin Vaccine Immunol       Date:  2006-11-01

Review 6.  The T-cell response to HIV.

Authors:  Bruce Walker; Andrew McMichael
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

7.  Premature aging of T cells is associated with faster HIV-1 disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Rita B Effros; Roger Detels
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

8.  Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.

Authors:  Prasanna Jagannathan; Christine M Osborne; Cassandra Royce; Maura M Manion; John C Tilton; Li Li; Steven Fischer; Claire W Hallahan; Julia A Metcalf; Mary McLaughlin; Matthew Pipeling; John F McDyer; Thomas J Manley; Jeffery L Meier; John D Altman; Laura Hertel; Richard T Davey; Mark Connors; Stephen A Migueles
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

9.  Heterogeneity of CD4+ and CD8+ T-cell responses to cytomegalovirus in HIV-infected and HIV-uninfected men who have sex with men.

Authors:  Huifen Li; Joseph B Margolick; Jay H Bream; Tricia L Nilles; Susan Langan; Hanhvy T Bui; Andrew W Sylwester; Louis J Picker; Sean X Leng
Journal:  J Infect Dis       Date:  2014-02-14       Impact factor: 5.226

10.  Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.

Authors:  Stephen A Migueles; Kristin A Weeks; Eric Nou; Amy M Berkley; Julia E Rood; Christine M Osborne; Claire W Hallahan; Nancy A Cogliano-Shutta; Julia A Metcalf; Mary McLaughlin; Richard Kwan; JoAnn M Mican; Richard T Davey; Mark Connors
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.